{"id":8243,"date":"2018-03-15T18:40:23","date_gmt":"2018-03-15T23:40:23","guid":{"rendered":"https:\/\/fomatmedical.com\/?p=8243"},"modified":"2026-05-07T15:50:18","modified_gmt":"2026-05-07T22:50:18","slug":"nicholas-focil-forbes-council","status":"publish","type":"post","link":"https:\/\/fomatmedical.com\/es\/company-updates\/nicholas-focil-forbes-council\/","title":{"rendered":"Forbes nomina a Nicholas Focil como miembro del Consejo Empresarial de Los \u00c1ngeles"},"content":{"rendered":"
\n
\n
\n
\n
\n
\n
\n

Nicholas Focil Forbes Council: Proud 2018 Official Member<\/h3>\n

Nicholas Focil Forbes Council membership was announced in Los Angeles, California on March 7, 2018, when FOMAT CEO Nicholas Focil was accepted into the Forbes Los Angeles Business Council, the foremost growth and networking organization for small businesses in Greater Los Angeles. Members are hand-selected to become part of a curated network of successful peers from across the region’s most dynamic industries. The recognition places Focil among an exclusive group of business leaders whose work is shaping the future of their respective fields.<\/p>\n

Commenting on the recognition, Focil stated that he was excited to be part of such a distinguished group of professionals and a prominent institution like Forbes, and looked forward to engaging with peers in candid discussions about the state of the industry and collaborating on how to best address its most pressing challenges. For Focil, the Nicholas Focil Forbes Council membership represents not just a personal milestone but a platform for advancing the broader mission of making clinical research more accessible, diverse, and impactful across the Americas.<\/p>\n

Forbes Councils combines an innovative, high-touch approach to community management developed by the team behind Young Entrepreneur Council with the extensive resources and global reach of Forbes. As a result, Nicholas Focil Forbes Council members gain access to the people, benefits, and expertise they need to grow their businesses and engage meaningfully with peers at the highest levels of their industries. The organization is selective by design, ensuring that every member brings demonstrated success and a commitment to contributing to the broader business community.<\/p>\n

Nicholas Focil Forbes Council Recognition Reflects a Career Built on Clinical Research Innovation<\/h3>\n

Nicholas Focil graduated in California with degrees in Biochemistry and an MBA. During his undergraduate studies, he spent time in a research laboratory working alongside a Nobel Prize nominated scientist on investigator initiated studies, an experience that shaped his deep understanding of how rigorous science translates into real world medical breakthroughs.<\/p>\n

After completing his Biochemistry degree, Focil was recruited by Medtronic MiniMed’s Diabetes division to coordinate pre-pivotal clinical trials. That role gave him firsthand experience in the operational demands of large scale clinical research and the importance of patient centered trial design. He subsequently became Managing Director of Diverse Research Solutions, where he was tasked with expanding clinical research operations across the United States.<\/p>\n

That expansion grew to include Latin America, where local CRO services were added and the organization evolved into what is now FOMAT. The growth reflected Focil’s conviction that underrepresented populations throughout the Americas deserved access to the same quality of clinical research available in established markets. With more than a decade of experience in clinical research leadership, Focil continues to serve as CEO, driving innovation and pioneering research in both the United States and Latin America.<\/p>\n

His professional profile is available at linkedin.com\/in\/nicholas-focil<\/a>.<\/p>\n

What the Nicholas Focil Forbes Council Membership Means for FOMAT<\/h3>\n

The Nicholas Focil Forbes Council membership reflects both his individual professional standing and FOMAT’s position as a recognized leader in clinical research innovation across the Americas. FOMAT is an international clinical research organization focused on innovating healthcare for underrepresented populations throughout the Americas. The organization believes that the future of healthcare lies in diversity and is committed to high quality management of clinical trials that improve and innovate care across all communities.<\/p>\n

Being part of the Forbes Los Angeles Business Council provides Focil with direct access to a network of leaders who understand the challenges of scaling mission driven organizations. For FOMAT, this visibility supports the company’s ongoing effort to build partnerships, attract talent, and expand its network of investigator sites across the United States and Latin America. The Nicholas Focil Forbes Council recognition is a reflection of the organization’s trajectory and the leadership that has driven it.<\/p>\n

About Forbes<\/h3>\n

Forbes is a global media, branding, and technology company with a focus on business, investing, technology, entrepreneurship, and leadership. Founded on September 15, 1917 by B.C. Forbes, the company now employs more than 400 people worldwide and reaches more than 94 million people each month through its magazines, 37 licensed local editions, Forbes.com, television, conferences, research, social and mobile platforms, with a magazine audience readership of 6.2 million.<\/p>\n

The original Nicholas Focil Forbes Council announcement was published via Yahoo Finance and is available at the Forbes nomination announcement<\/a>.<\/p>\n

FOMAT conducts Phase I through Phase IV clinical research across a national network of investigator sites throughout the United States. To learn more about our services and active studies, visit our services page<\/a>.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Nicholas Focil, miembro del Consejo Forbes: Orgulloso miembro oficial de 2018. La incorporaci\u00f3n de Nicholas Focil al Consejo Forbes se anunci\u00f3 en Los \u00c1ngeles, California, el 7 de marzo de 2018, cuando Nicholas Focil, director ejecutivo de FOMAT, fue admitido en el Consejo Empresarial de Forbes de Los \u00c1ngeles, el principal foro dedicado al crecimiento y\u2026<\/p>","protected":false},"author":3,"featured_media":111279,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","footnotes":""},"categories":[901],"tags":[918,915,912,916,919],"class_list":["post-8243","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-updates","tag-clinical-research","tag-clinical-trials","tag-fomat","tag-fomat-medical-research","tag-nicholas-focil"],"acf":[],"_links":{"self":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/posts\/8243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/comments?post=8243"}],"version-history":[{"count":0,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/posts\/8243\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/media\/111279"}],"wp:attachment":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/media?parent=8243"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/categories?post=8243"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/tags?post=8243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}